+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of small molecule inhibitors of neurite loss induced by Aβ peptide using high content screening



Identification of small molecule inhibitors of neurite loss induced by Aβ peptide using high content screening



Journal of Biological Chemistry 287(12): 8714-8723



Multiple lines of evidence indicate a strong relationship between Αβ peptide-induced neurite degeneration and the progressive loss of cognitive functions in Alzheimer disease (AD) patients and in AD animal models. This prompted us to develop a high content screening assay (HCS) and Neurite Image Quantitator (NeuriteIQ) software to quantify the loss of neuronal projections induced by Aβ peptide neurons and enable us to identify new classes of neurite-protective small molecules, which may represent new leads for AD drug discovery. We identified thirty-six inhibitors of Aβ-induced neurite loss in the 1,040-compound National Institute of Neurological Disorders and Stroke (NINDS) custom collection of known bioactives and FDA approved drugs. Activity clustering showed that non-steroidal anti-inflammatory drugs (NSAIDs) were significantly enriched among the hits. Notably, NSAIDs have previously attracted significant attention as potential drugs for AD; however their mechanism of action remains controversial. Our data revealed that cyclooxygenase-2 (COX-2) expression was increased following Aβ treatment. Furthermore, multiple distinct classes of COX inhibitors efficiently blocked neurite loss in primary neurons, suggesting that increased COX activity contributes to Aβ peptide-induced neurite loss. Finally, we discovered that the detrimental effect of COX activity on neurite integrity may be mediated through the inhibition of peroxisome proliferator-activated receptor γ (PPARγ) activity. Overall, our work establishes the feasibility of identifying small molecule inhibitors of Aβ-induced neurite loss using the NeuriteIQ pipeline and provides novel insights into the mechanisms of neuroprotection by NSAIDs.

(PDF emailed within 0-6 h: $19.90)

Accession: 053671149

Download citation: RISBibTeXText

PMID: 22277654

DOI: 10.1074/jbc.M111.290957


Related references

Identification of small-molecule HSF1 amplifiers by high content screening in protection of cells from stress induced injury. Biochemical and Biophysical Research Communications 390(3): 925-930, 2009

Screening and identification of small molecule inhibitors of ErbB2-induced invasion. Molecular Oncology 8(8): 1703-1718, 2015

A high throughput screening assay system for the identification of small molecule inhibitors of gsp. Plos One 9(3): E90766-E90766, 2015

Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening. 2013

High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Research 134(): 6-16, 2016

Identification of small molecule inhibitors of p27(Kip1) ubiquitination by high-throughput screening. Cancer Science 104(11): 1461-1467, 2014

High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase. Journal of Biomolecular Screening 9(5): 391-397, 2004

Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening. Bioscience Trends 6(4): 192-200, 2013

Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach. Journal of Controlled Release 170(1): 132-140, 2014

High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Analytical Biochemistry 320(1): 66-74, September 1, 2003

High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists. Molecular Pharmacology 71(4): 1061-1074, 2007

High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate). Analytical Biochemistry 298(1): 62-68, 2001

High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1. Journal of Biomolecular Screening 18(8): 910-920, 2014

Identification of novel small-molecule inhibitors for human transketolase by high-throughput screening with fluorescent intensity (FLINT) assay. Journal of Biomolecular Screening 9(5): 427-433, 2004

Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform. Journal of Biomolecular Screening 13(9): 870-878, 2008